公告日期：2024-12-13

Pharma Corporation

Jacobson Pharma Corporation Limited

雅 各 臣 科 研 製 藥 有 限 公 司

(Incorporated in the Cayman Islands with limited liability)

（於開曼群島註冊成立的有限公司）

(Stock Code 股份代號：2633)

NOTIFICATION LETTER 通知信函

16 December 2024
Dear Registered Shareholder(s),

Jacobson Pharma Corporation Limited (the “Company”)

– Notice of publication of 2024/2025 Interim Report (the “Current Corporate Communication”)

The English and Chinese versions of the Company’s Current Corporate Communication are now available on the Company’s website at www.jacobsonpharma.com and the website
of The Stock Exchange of Hong Kong Limited at www.hkexnews.hk respectively (the “Website Version”). The Company strongly recommends you to access the Website Version
of the Current Corporate Communication and all future Corporate Communications(Note1). If you have elected to receive the Corporate Communications in printed form, the Current
Corporate Communication are enclosed.

If you for any reason have difficulty in receiving email notification or gaining access to the Website Version of the Current Corporate Communication and would like to receive the
Current Corporate Communication and all future Corporate Communications in printed form, please complete, sign the enclosed Reply Form and return it to the Company’s branch
share registrar in Hong Kong, Tricor Investor Services Limited (the “Branch Share Registrar”) at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong by post using the
provided prepaid mailing label (no stam……
[点击查看PDF原文][查看历史公告]

提示：本网不保证其真实性和客观性，一切有关该股的有效信息，以交易所的公告为准，敬请投资者注意风险。